146 related articles for article (PubMed ID: 16421260)
1. Interpretation of scintigraphic findings of oral malignant tumours with a new scanning agent of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile (Tc-99m-MIBI).
Sato T; Kawabata Y; Saigo Y; Iwashita Y; Suenaga S; Indo H; Hamahira S; Kawano K; Nitta T; Morita Y; Majima H; Sugihara K
Dentomaxillofac Radiol; 2006 Jan; 35(1):24-9. PubMed ID: 16421260
[TBL] [Abstract][Full Text] [Related]
2. Scintigraphy for interpretation of malignant tumours of the head and neck: comparison of technetium-99m-hexakis-2-methoxyisobutylisonitrile (Tc-MIBI) and thallium-201-chloride (Tl-201).
Sato T; Kawabata Y; Kobayashi Y; Suenaga S; Indo H; Kawano K; Iwashita Y; Morita Y; Majima HJ
Dentomaxillofac Radiol; 2005 Sep; 34(5):268-73. PubMed ID: 16120875
[TBL] [Abstract][Full Text] [Related]
3. Expression of permeability-glycoprotein (P-gp) and uptake of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile (99Tcm-MIBI) in malignant tumour of the head and neck.
Sato T; Kawabata Y; Nitta T; Saigo Y; Iwashita Y; Suenaga S; Hamahira S; Indo H; Morita Y; Majima HJ; Sugihara K
Dentomaxillofac Radiol; 2005 Sep; 34(5):274-8. PubMed ID: 16120876
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-MIBI imaging of cutaneous AIDS-associated Kaposi's sarcoma.
Peer FI; Pui MH; Mosam A; Rae WI
Int J Dermatol; 2007 Feb; 46(2):166-71. PubMed ID: 17269969
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
Moustafa H; Riad R; Omar W; Zaher A; Ebied E
Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
[TBL] [Abstract][Full Text] [Related]
7. Renal and hepatic kinetics of Tc-99m-labelled hexakis-methoxy-isobutyl Isonitrile.
Dizdarevic S; Aplin M; Ryan N; Holt SG; Goldberg L; Miles KA; Peters AM
Drug Metab Lett; 2012; 6(4):242-6. PubMed ID: 23745949
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of Tc-99m MIBI scintigraphy in the differential diagnosis of malign and benign of intrathoracic pathologies].
Boyaci H; Berk F; Ilgazli A; Erçin C; Yildiz F; Sengül C
Tuberk Toraks; 2003; 51(2):157-62. PubMed ID: 15143422
[TBL] [Abstract][Full Text] [Related]
9. A comparison of radionuclide thyroid angiography, (99m)Tc-MIBI scintigraphy and power Doppler ultrasonography in the differential diagnosis of solitary cold thyroid nodules.
Demirel K; Kapucu O; Yücel C; Ozdemir H; Ayvaz G; Taneri F
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):642-50. PubMed ID: 12612810
[TBL] [Abstract][Full Text] [Related]
10. The role of Tc-99m MIBI scintigraphy in clinical T1 renal mass assessment: Does it have a real benefit?
Asi T; Tuncali MÇ; Tuncel M; Alkanat NEİ; Hazir B; Kösemehmetoğlu K; Baydar DE; Akdoğan B
Urol Oncol; 2020 Dec; 38(12):937.e11-937.e17. PubMed ID: 32859460
[TBL] [Abstract][Full Text] [Related]
11. Prescintigraphic morphine application for abdominal adenocarcinoma imaging, with technetium-99m methoxy isobutyl isonitrile.
Ferlitsch A; Steindl-Munda P; Haefner M; Peck-Radosavljevic M; Madl C; Pötzi R; Homoncik M; Weidekamm C; Granegger S; Sinzinger H
Hell J Nucl Med; 2007; 10(1):14-8. PubMed ID: 17450244
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
J Nucl Med; 1998 Jul; 39(7):1166-71. PubMed ID: 9669388
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implications for pre-therapeutic prediction of treatment outcomes with (99m)Tc-sestamibi, (201)Tl chloride and (99m)Tc-HL91.
Kinuya S; Yokoyama K; Li XF; Bai J; Watanabe N; Shuke N; Takayama T; Bunko H; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1006-11. PubMed ID: 12173013
[TBL] [Abstract][Full Text] [Related]
14. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs.
Hassan IM; Sahweil A; Constantinides C; Mahmoud A; Nair M; Omar YT; Abdel-Dayem HM
Clin Nucl Med; 1989 May; 14(5):333-40. PubMed ID: 2721076
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
Duan XY; Wang JS; Liu M; Guo YM
Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987
[TBL] [Abstract][Full Text] [Related]
16. [Thyroid scintigraphy in patients with thyroid tumors using 99mTc-hexakis 2-methoxy isobutyl isonitrile].
Kosuda S; Arai S; Katayama M; Yokoyama H; Kusano S; Nakanobo M; Nohara S; Inoue T
Kaku Igaku; 1994 Nov; 31(11):1335-42. PubMed ID: 7837701
[TBL] [Abstract][Full Text] [Related]
17. A single (99m)Tc-MIBI study to predict response to neoadjuvant treatment in sarcoma patiens.
Sohaib M; Wiqar MA; Ali MK; Hussain F; Umer-i-Farooq
Hell J Nucl Med; 2011; 14(2):140-5. PubMed ID: 21761016
[TBL] [Abstract][Full Text] [Related]
18. Investigation of blood perfusion and metabolic activity of brain tumours in adults by using 99mTc-methoxyisobutylisonitrile.
Petrovic NS; Grujicic D; Artiko VM; Sobic-Saranovic DP; Gajic MM; Jaksic E; Grajic MM; Antonovic OJ; Petrovic MN; Obradovic VB
Nucl Med Commun; 2010 Nov; 31(11):962-73. PubMed ID: 20802363
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma.
Del Vecchio S; Zannetti A; Aloj L; Caracò C; Ciarmiello A; Salvatore M
Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):879-87. PubMed ID: 12721767
[TBL] [Abstract][Full Text] [Related]
20. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
Ozcan Z; Burak Z; Erinç R; Dirlik A; Başdemir G; Sabah D; Ozkiliç H
Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
